{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:47:44Z","timestamp":1792273664581,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["1919B012224171"],"award-info":[{"award-number":["1919B012224171"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10735-026-10943-8","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:46:56Z","timestamp":1787017616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective effects of myricetin against rotenone-\u0131nduced parkinsonian neurotoxicity: a multidimensional analysis in rats"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9018-7849","authenticated-orcid":false,"given":"Onural","family":"Ozhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0957-7759","authenticated-orcid":false,"given":"Zehranur","family":"Erikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5686-7867","authenticated-orcid":false,"given":"Azibe","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7949-9582","authenticated-orcid":false,"given":"Feyzi","family":"Dogru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7956-9272","authenticated-orcid":false,"given":"Zeynep","family":"Kucukakcali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-3468","authenticated-orcid":false,"given":"Hakan","family":"Parlakpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"10943_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.curtheres.2013.03.001","volume":"74","author":"M Ali Erdogan","year":"2013","unstructured":"Ali Erdogan M, Polat A, Yucel A et al (2013) Effects of perineural administration of dexmedetomidine in combination with levobupivacaine in a rat sciatic nerve block. Curr Ther Res Clin Exp 74:74\u201378. https:\/\/doi.org\/10.1016\/j.curtheres.2013.03.001","journal-title":"Curr Ther Res Clin Exp"},{"key":"10943_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094188","author":"S Almatroodi","year":"2025","unstructured":"Almatroodi S, Rahmani A (2025) Unlocking the pharmacological potential of myricetin against various pathogenesis. Int J Molecular Sci. https:\/\/doi.org\/10.3390\/ijms26094188","journal-title":"Int J Molecular Sci"},{"key":"10943_CR3","unstructured":"Bergmeyer H-u. (1963). Methods of enzymatic analysis. Weinheim, W. Germany: Verlag Chemie, GmbH; New York and London: Academic Press."},{"key":"10943_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G et al (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3:1301\u20131306. https:\/\/doi.org\/10.1038\/81834","journal-title":"Nat Neurosci"},{"key":"10943_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1021\/tx049867r","volume":"17","author":"P Caboni","year":"2004","unstructured":"Caboni P, Sherer TB, Zhang N et al (2004) Rotenone, deguelin, their metabolites, and the rat model of Parkinson\u2019s disease. Chem Res Toxicol 17:1540\u20131548. https:\/\/doi.org\/10.1021\/tx049867r","journal-title":"Chem Res Toxicol"},{"key":"10943_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM et al (2009) A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis 34:279\u2013290. https:\/\/doi.org\/10.1016\/j.nbd.2009.01.016","journal-title":"Neurobiol Dis"},{"key":"10943_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2478\/acph-2022-0008","volume":"72","author":"Y Casanova","year":"2021","unstructured":"Casanova Y, Negro S, Barcia E (2021) Application of neurotoxin- and pesticide-induced animal models of Parkinson\u2019s disease in the evaluation of new drug delivery systems. Acta Pharm 72:35\u201358. https:\/\/doi.org\/10.2478\/acph-2022-0008","journal-title":"Acta Pharm"},{"key":"10943_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1134464","author":"T Chen","year":"2023","unstructured":"Chen T, Hu Y, Lu L et al (2023) Myricetin attenuates hypoxic-ischemic brain damage in neonatal rats via NRF2 signaling pathway. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1134464","journal-title":"Front Pharmacol"},{"key":"10943_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1055\/s-0033-1363220","volume":"64","author":"Y Dang","year":"2014","unstructured":"Dang Y, Lin G, Xie Y et al (2014) Quantitative determination of myricetin in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its absolute bioavailability. Drug Res (Stuttg) 64:516\u2013522. https:\/\/doi.org\/10.1055\/s-0033-1363220","journal-title":"Drug Res (Stuttg)"},{"key":"10943_CR11","doi-asserted-by":"publisher","first-page":"8914","DOI":"10.3390\/cimb46080527","volume":"46","author":"G Demyashkin","year":"2024","unstructured":"Demyashkin G, Blinova E, Grigoryan M et al (2024) Neuroprotective effects of myricetin on PTZ-induced seizures in mice: evaluation of oxidation, neuroinflammation and metabolism, and apoptosis in the hippocampus. Curr Issues Mol Biol 46:8914\u20138944. https:\/\/doi.org\/10.3390\/cimb46080527","journal-title":"Curr Issues Mol Biol"},{"key":"10943_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.4103\/1673-5374.300461","volume":"16","author":"H Deng","year":"2020","unstructured":"Deng H, Liu S, Pan D et al (2020) Myricetin reduces cytotoxicity by suppressing hepcidin expression in MES23.5 cells. Neural Regen Res 16:1105\u20131110. https:\/\/doi.org\/10.4103\/1673-5374.300461","journal-title":"Neural Regen Res"},{"key":"10943_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.22159\/IJPPS.2017V9I11.19931","volume":"9","author":"V Dhanraj","year":"2017","unstructured":"Dhanraj V, Manivasagam T, Karuppaiah J (2017) Myricetin isolated from Turbinaria ornata ameliorates rotenone induced parkinsonism in Drosophila melanogaster. Int J Pharm Pharm Sci 9:39\u201344. https:\/\/doi.org\/10.22159\/IJPPS.2017V9I11.19931","journal-title":"Int J Pharm Pharm Sci"},{"key":"10943_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2741\/E835","volume":"10","author":"V Dhanraj","year":"2018","unstructured":"Dhanraj V, Karuppaiah J, Balakrishnan R et al (2018) Myricetin attenuates neurodegeneration and cognitive impairment in Parkinsonism. Front Biosci 10:481\u2013494. https:\/\/doi.org\/10.2741\/E835","journal-title":"Front Biosci"},{"key":"10943_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/jpd-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3:461\u2013491. https:\/\/doi.org\/10.3233\/jpd-130230","journal-title":"J Parkinsons Dis"},{"key":"10943_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124775","author":"Z El-Gendy","year":"2024","unstructured":"El-Gendy Z, Ammar N, Kassem A et al (2024) Myricetin-loaded SBA-15 silica nanoparticles for enhanced management of pyrexia, pain, and inflammation through modulation of MAPK\/NF-kB and COX-2\/PGE-2 pathways: evidence from the biochemical, histological, and metabolomic analysis. Int J Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124775","journal-title":"Int J Pharm"},{"key":"10943_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377. https:\/\/doi.org\/10.1016\/0003-9861(59)90090-6","journal-title":"Arch Biochem Biophys"},{"key":"10943_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277\u2013285. https:\/\/doi.org\/10.1016\/j.clinbiochem.2003.11.015","journal-title":"Clin Biochem"},{"key":"10943_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103\u20131111. https:\/\/doi.org\/10.1016\/j.clinbiochem.2005.08.008","journal-title":"Clin Biochem"},{"key":"10943_CR20","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"N Exner","year":"2012","unstructured":"Exner N, Lutz AK, Haass C et al (2012) Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences. EMBO J 31:3038\u20133062. https:\/\/doi.org\/10.1038\/emboj.2012.170","journal-title":"EMBO J"},{"key":"10943_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11064-020-03209-6","volume":"46","author":"OM Farag","year":"2021","unstructured":"Farag OM, Abd-Elsalam RM, Ogaly HA et al (2021) Metabolomic profiling and neuroprotective effects of purslane seeds extract against acrylamide toxicity in rat\u2019s brain. Neurochem Res 46:819\u2013842. https:\/\/doi.org\/10.1007\/s11064-020-03209-6","journal-title":"Neurochem Res"},{"key":"10943_CR22","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/jneurosci.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Salcedo J, Fernagut PO et al (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 24:9434\u20139440. https:\/\/doi.org\/10.1523\/jneurosci.3080-04.2004","journal-title":"J Neurosci"},{"key":"10943_CR23","unstructured":"Garber JC, Wayne Barbee R, Bielitzki JT et al (2011) Committee for the Update of the Guide for the Care and Use of Laboratory Animals."},{"key":"10943_CR24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/s1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson's Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. https:\/\/doi.org\/10.1016\/s1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"10943_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62910-6","volume":"14","author":"S-C Gu","year":"2024","unstructured":"Gu S-C, Xie Z-G, Gu M-J et al (2024) Myricetin mitigates motor disturbance and decreases neuronal ferroptosis in a rat model of Parkinson\u2019s disease. Sci Rep 14:15107. https:\/\/doi.org\/10.1038\/s41598-024-62910-6","journal-title":"Sci Rep"},{"key":"10943_CR27","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ejpain.2010.04.005","volume":"14","author":"T Hagenacker","year":"2010","unstructured":"Hagenacker T, Hillebrand I, Wissmann A et al (2010) Anti-allodynic effect of the flavonoid myricetin in a rat model of neuropathic pain: involvement of p38 and protein kinase C mediated modulation of Ca2+ channels. Eur J Pain 14:992\u2013998. https:\/\/doi.org\/10.1016\/j.ejpain.2010.04.005","journal-title":"Eur J Pain"},{"key":"10943_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"10943_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.797298","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Xiang H, Huang C et al (2021) Pharmacological actions of myricetin in the nervous system: a comprehensive review of preclinical studies in animals and cell models. Front Pharmacol 12:797298. https:\/\/doi.org\/10.3389\/fphar.2021.797298","journal-title":"Front Pharmacol"},{"key":"10943_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/WNR.0b013e32821c51fe","volume":"18","author":"ZG Ma","year":"2007","unstructured":"Ma ZG, Wang J, Jiang H et al (2007) Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats. NeuroReport 18:1181\u20131185. https:\/\/doi.org\/10.1097\/WNR.0b013e32821c51fe","journal-title":"NeuroReport"},{"key":"10943_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","volume":"86","author":"M Mihara","year":"1978","unstructured":"Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271\u2013278. https:\/\/doi.org\/10.1016\/0003-2697(78)90342-1","journal-title":"Anal Biochem"},{"issue":"1-2","key":"10943_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0014-2999(03)01902-2","volume":"472","author":"M Molina-Jim\u00e9nez","year":"2003","unstructured":"Molina-Jim\u00e9nez M, S\u00e1nchez-Reus M, Bened\u00ed J (2003) Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SH-SY5Y cells: comparison with N-acetylcysteine. Eur J Pharmacol 472(1\u20132):81\u201387. https:\/\/doi.org\/10.1016\/S0014-2999(03)01902-2","journal-title":"Eur J Pharmacol"},{"key":"10943_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainres.2004.02.065","volume":"1009","author":"M Molina-Jim\u00e9nez","year":"2004","unstructured":"Molina-Jim\u00e9nez M, S\u00e1nchez-Reus M, Andr\u00e9s D et al (2004) Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res 1009:9\u201316. https:\/\/doi.org\/10.1016\/j.brainres.2004.02.065","journal-title":"Brain Res"},{"key":"10943_CR34","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011","unstructured":"National Research Council (2011) Guide for the care and use of laboratory animals, 8th edition ed. National Academies Press","edition":"8th edition ed."},{"key":"10943_CR35","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.26355\/eurrev_202306_32823","volume":"27","author":"O Ozhan","year":"2023","unstructured":"Ozhan O, Izci SF, Huz M et al (2023) Therapeutic effects of cinnamon bark oil on sciatic nerve injury in rats. Eur Rev Med Pharmacol Sci 27:5841\u20135853. https:\/\/doi.org\/10.26355\/eurrev_202306_32823","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10943_CR36","first-page":"158","volume":"70","author":"DE Paglia","year":"1967","unstructured":"Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158\u2013169","journal-title":"J Lab Clin Med"},{"key":"10943_CR37","doi-asserted-by":"publisher","first-page":"42026","DOI":"10.1074\/jbc.M508628200","volume":"280","author":"A Panov","year":"2005","unstructured":"Panov A, Dikalov S, Shalbuyeva N et al (2005) Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 280:42026\u201342035. https:\/\/doi.org\/10.1074\/jbc.M508628200","journal-title":"J Biol Chem"},{"key":"10943_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-020-02451-y","volume":"16","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. BMC Vet Res 16:242. https:\/\/doi.org\/10.1186\/s12917-020-02451-y","journal-title":"BMC Vet Res"},{"key":"10943_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"10943_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","volume":"67","author":"Y Porat","year":"2006","unstructured":"Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug des 67:27\u201337. https:\/\/doi.org\/10.1111\/j.1747-0285.2005.00318.x","journal-title":"Chem Biol Drug des"},{"key":"10943_CR41","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.4103\/1673-5374.197141","volume":"11","author":"M Ramezani","year":"2016","unstructured":"Ramezani M, Darbandi N, Khodagholi F et al (2016) Myricetin protects hippocampal CA3 pyramidal neurons and improves learning and memory impairments in rats with Alzheimer\u2019s disease. Neural Regen Res 11:1976\u20131980. https:\/\/doi.org\/10.4103\/1673-5374.197141","journal-title":"Neural Regen Res"},{"key":"10943_CR42","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.32604\/biocell.2025.066320","volume":"49","author":"C Rubio","year":"2025","unstructured":"Rubio C, Serrano-Garc\u00edA N, Taddei E et al (2025) Rotenone-induced mitochondrial dysfunction, neuroinflammation, oxidative stress, and glial activation in Parkinson\u2019s and Alzheimer\u2019s diseases. Biocell 49:1391\u20131412. https:\/\/doi.org\/10.32604\/biocell.2025.066320","journal-title":"Biocell"},{"key":"10943_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/s0028-3908(00)00005-8","volume":"39","author":"T Schallert","year":"2000","unstructured":"Schallert T, Fleming SM, Leasure JL et al (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777\u2013787. https:\/\/doi.org\/10.1016\/s0028-3908(00)00005-8","journal-title":"Neuropharmacology"},{"key":"10943_CR44","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/s0140-6736(89)92366-0","volume":"1","author":"AH Schapira","year":"1989","unstructured":"Schapira AH, Cooper JM, Dexter D et al (1989) Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 1:1269. https:\/\/doi.org\/10.1016\/s0140-6736(89)92366-0","journal-title":"Lancet"},{"key":"10943_CR45","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2174\/1871527322666230718105358","volume":"23","author":"NK Sethiya","year":"2024","unstructured":"Sethiya NK, Ghiloria N, Srivastav A et al (2024) Therapeutic potential of myricetin in the treatment of neurological, neuropsychiatric, and neurodegenerative disorders. CNS Neurol Disord Drug Targets 23:865\u2013882. https:\/\/doi.org\/10.2174\/1871527322666230718105358","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10943_CR46","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1523\/jneurosci.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM et al (2003) Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J Neurosci 23:10756\u201310764. https:\/\/doi.org\/10.1523\/jneurosci.23-34-10756.2003","journal-title":"J Neurosci"},{"key":"10943_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111017","volume":"134","author":"X Song","year":"2021","unstructured":"Song X, Tan L, Wang M et al (2021) Myricetin: a review of the most recent research. Biomed Pharmacother 134:111017. https:\/\/doi.org\/10.1016\/j.biopha.2020.111017","journal-title":"Biomed Pharmacother"},{"key":"10943_CR48","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/clinchem\/34.3.497","volume":"34","author":"Y Sun","year":"1988","unstructured":"Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497\u2013500","journal-title":"Clin Chem"},{"key":"10943_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-020-03033-z","author":"Y Taheri","year":"2020","unstructured":"Taheri Y, Suleria H, Martins N et al (2020) Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications. BMC Complement Med Therapies. https:\/\/doi.org\/10.1186\/s12906-020-03033-z","journal-title":"BMC Complement Med Therapies"},{"key":"10943_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bjorl.2021.07.001","volume":"88","author":"M Tan","year":"2022","unstructured":"Tan M, Toplu Y, Varan E et al (2022) The effect of genistein on cisplatin induced ototoxicity and oxidative stress. Braz J Otorhinolaryngol 88:105\u2013111. https:\/\/doi.org\/10.1016\/j.bjorl.2021.07.001","journal-title":"Braz J Otorhinolaryngol"},{"key":"10943_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2025.110470","volume":"770","author":"PAK Tinku","year":"2025","unstructured":"Tinku PAK, Sahoo S et al (2025) Mechanism of flavonoid myricetin modulated aggregation in \u03b1-Synuclein and its familial mutants E46K and A30P. Arch Biochem Biophys 770:110470. https:\/\/doi.org\/10.1016\/j.abb.2025.110470","journal-title":"Arch Biochem Biophys"},{"key":"10943_CR52","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12272-009-1408-6","volume":"32","author":"Y Tong","year":"2009","unstructured":"Tong Y, Zhou X, Wang S-J et al (2009) Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves. Arch Pharm Res 32:527\u2013533. https:\/\/doi.org\/10.1007\/s12272-009-1408-6","journal-title":"Arch Pharm Res"},{"key":"10943_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2021.04.006","volume":"173","author":"D Troshev","year":"2021","unstructured":"Troshev D, Berezhnoy D, Kulikova O et al (2021) The dynamics of nigrostriatal system damage and neurobehavioral changes in the rotenone rat model of Parkinson\u2019s disease. Brain Res Bull 173:1\u201313. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.04.006","journal-title":"Brain Res Bull"},{"key":"10943_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101695","volume":"37","author":"VS Van Laar","year":"2020","unstructured":"Van Laar VS, Chen J, Zharikov AD et al (2020) \u03b1-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo. Redox Biol 37:101695. https:\/\/doi.org\/10.1016\/j.redox.2020.101695","journal-title":"Redox Biol"},{"key":"10943_CR55","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","volume":"83","author":"RN Walsh","year":"1976","unstructured":"Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83:482\u2013504","journal-title":"Psychol Bull"},{"key":"10943_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/0-89603-062-8:1","volume":"1","author":"JH Waterborg","year":"1984","unstructured":"Waterborg JH, Matthews HR (1984) The lowry method for protein quantitation. Methods Mol Biol 1:1\u20133. https:\/\/doi.org\/10.1385\/0-89603-062-8:1","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10943_CR57","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1039\/c6fo00419a","volume":"7","author":"S Wu","year":"2016","unstructured":"Wu S, Yue Y, Peng A et al (2016) Myricetin ameliorates brain injury and neurological deficits via Nrf2 activation after experimental stroke in middle-aged rats. Food Funct 7(6):2624\u20132634. https:\/\/doi.org\/10.1039\/c6fo00419a","journal-title":"Food Funct"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10943-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:19:10Z","timestamp":1792271950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10943-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10943"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10943-8","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"28 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical committee approval was obtained from the Inonu University Faculty of Medicine Animal Experiments Local Ethics Committee on November 9, 2023, at the meeting numbered 2023\/11\u20131.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"273"}}